...
首页> 外文期刊>Journal of Korean medical science >Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo
【24h】

Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo

机译:Acer tegmentosum Maxim水提取物的体外和体内抗血管生成活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Angiogenesis, the formation of new blood vessels, is critical for tumor growth and metastasis. Notably, tumors themselves can lead to angiogenesis by inducing vascular endothelial growth factor (VEGF), which is one of the most potent angiogenic factors. Inhibition of angiogenesis is currently perceived as one of the most promising strategies for the blockage of tumor growth. In this study, we investigated the effects of Acer tegmentosum maxim water extract (ATME) on angiogenesis and its underlying signal mechanism. We studied the antiangiogenic activity of ATME by using human umbilical vein endothelial cells (HUVECs). ATME strongly inhibited VEGF-induced endothelial cell proliferation, migration, invasion, and tube formation, as well as vessel sprouting in a rat aortic ring sprouting assay. Moreover, we found that the p44/42 mitogen activated protein (MAP) kinase signaling pathway is involved in the inhibition of angiogenesis by ATME. Moreover, when we performed the in vivo matrigel plug assay, VEGF-induced angiogenesis was potently reduced when compared to that for the control group. Taken together, these results suggest that ATME exhibits potent antiangiogenic activity in vivo and in vitro and that these effects are regulated by the extracellular regulated kinase (ERK) pathway.
机译:血管生成,即新血管的形成,对于肿瘤的生长和转移至关重要。值得注意的是,肿瘤本身可以通过诱导血管内皮生长因子(VEGF)来诱导血管生成,VEGF是最有效的血管生成因子之一。目前认为抑制血管生成是阻止肿瘤生长的最有希望的策略之一。在这项研究中,我们调查了枫叶枫宏水提取物(ATME)对血管生成及其潜在信号机制的影响。我们通过使用人脐静脉内皮细胞(HUVEC)研究了ATME的抗血管生成活性。在大鼠主动脉环发芽试验中,ATME强烈抑制VEGF诱导的内皮细胞增殖,迁移,侵袭和管形成以及血管发芽。此外,我们发现p44 / 42丝裂原活化蛋白(MAP)激酶信号通路参与了ATME对血管生成的抑制。此外,当我们进行体内基质胶栓塞测定时,与对照组相比,VEGF诱导的血管生成明显减少。综上所述,这些结果表明ATME在体内和体外均表现出有效的抗血管生成活性,并且这些作用受细胞外调节激酶(ERK)途径的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号